Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionStone Point Wealth LLC
Latest Disclosed Ownership31,246 shares
Latest Disclosed Value $ 4,354,755
Stone Point Wealth LLC reports 4.03% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 22, 2026 - Stone Point Wealth LLC filed a 13F-HR form disclosing ownership of 31,246 shares of Gilead Sciences, Inc. (CH:GILD) valued at $4,354,755 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 32,557 shares of Gilead Sciences, Inc.. This represents a change in shares of -4.03% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F GILEAD SCIENCES COM 375558103 31,246 -1,311 -4.03 4,355 8.96 1.2119
2026-01-27 2025-12-31 13F GILEAD SCIENCES COM 375558103 32,557 -206 -0.63 3,996 9.90 1.0838
2025-10-22 2025-09-30 13F GILEAD SCIENCES COM 375558103 32,763 -160 -0.49 3,637 -0.38 1.0314
2025-07-17 2025-06-30 13F GILEAD SCIENCES COM 375558103 32,923 575 1.78 3,650 0.72 1.1308
2025-04-24 2025-03-31 13F GILEAD SCIENCES COM 375558103 32,348 1,845 6.05 3,625 28.65 1.2278
2025-01-28 2024-12-31 13F GILEAD SCIENCES COM 375558103 30,503 1,798 6.26 2,818 17.08 0.9455
2024-10-31 2024-09-30 13F GILEAD SCIENCES COM 375558103 28,705 487 1.73 2,407 24.28 0.7765
2024-07-30 2024-06-30 13F GILEAD SCIENCES COM 375558103 28,218 -7,254 -20.45 1,936 -25.48 0.6942
2024-05-01 2024-03-31 13F GILEAD SCIENCES COM 375558103 35,472 1,214 3.54 2,598 -6.38 0.9032
2024-01-26 2023-12-31 13F GILEAD SCIENCES COM 375558103 34,258 -2,312 -6.32 2,775 1.28 1.0643
2023-10-25 2023-09-30 13F GILEAD SCIENCES COM 375558103 36,570 2,722 8.04 2,741 5.06 1.1746
2023-07-25 2023-06-30 13F GILEAD SCIENCES COM 375558103 33,848 1,278 3.92 2,609 -3.48 1.0807
2023-04-20 2023-03-31 13F GILEAD SCIENCES COM 375558103 32,570 6,950 27.13 2,702 22.87 1.2013
2023-01-20 2022-12-31 13F GILEAD SCIENCES COM 375558103 25,620 2,385 10.26 2,199 53.35 1.0786
2022-11-03 2022-09-30 13F GILEAD SCIENCES COM 375558103 23,235 1,475 6.78 1,434 6.62 0.8814
2022-07-19 2022-06-30 13F GILEAD SCIENCES COM 375558103 21,760 -382 -1.73 1,345 1.66 0.8028
2022-04-29 2022-03-31 13F GILEAD SCIENCES COM 375558103 22,142 6,907 45.34 1,323 19.40 0.7412
2022-02-10 2021-12-31 13F GILEAD SCIENCES COM 375558103 15,235 15,235 1,108 0.8988
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.